Merck, Schering to combine blockbusters

Why not build on success? Schering-Plough and Merck are asking the FDA to approve a pill that combines the active ingredients of Singulair, the blockbuster asthma-and-allergy remedy, and Claritin, another best-selling allergy drug that went generic and over-the-counter in 2002. Under development by a joint venture of the two companies, the new product has been accepted for the FDA's standard review process.

- see the release on the combination package

Related Articles:
Drug combos not a sure thing. Report
New combos of old drugs may be boon to biotech. Report
New combo cholesterol drug being planned. Report